Over-the-counter vs. prescription medications: are consumer perceptions of the consequences of drug instruction non-compliance different?

被引:12
作者
Bower, Amanda B. [1 ]
Grau, Stacy Landreth [2 ]
Taylor, Valerie A. [3 ]
机构
[1] Washington & Lee Univ, Williams Sch Commerce Econ & Polit, Lexington, VA 24450 USA
[2] Texas Christian Univ, Neeley Sch Business, Ft Worth, TX 76129 USA
[3] Univ Tennessee, Coll Business, Chattanooga, TN 37403 USA
关键词
Medication compliance; usage instructions; instruction compliance; over-the-counter; prescription medication usage; WARNING MESSAGES; EMERGENCY; SWITCH;
D O I
10.1111/j.1470-6431.2011.01093.x
中图分类号
F [经济];
学科分类号
02 ;
摘要
Over-the-counter (OTC) medications are widely available and are extensively used by consumers to treat a range of health maladies. These medications are viewed as both safe and effective when used appropriately. However, the US Food and Drug Administration cautions that very serious adverse reactions frequently result from overdose of common OTC medications. The frequency and severity of these adverse reactions stemming from non-compliance with OTC usage suggest that these medications may not be treated with the same level of care by consumers as those afforded to prescription drugs. Consequently, the purpose of the present research is to investigate the different perceptions consumers may have regarding the importance of complying with the drug instructions for prescription vs. OTC medications. Results suggest that when considering compliance attitudes and intentions towards the usage instructions of a new and unfamiliar medication, subjects do not perceive there to be an initial difference in the consequences of non-compliance with drug instructions across the two classification conditions. However, when thinking about OTC and prescription drug instructions in general, subjects tend to take the prescription drug instructions more seriously. While further studies are obviously needed, these preliminary results provide insight into consumer perception of non-compliance with different classes of medications.
引用
收藏
页码:228 / 233
页数:6
相关论文
共 37 条
[1]  
Andrews J. C., 1995, MARKETING CONSUMER B, P153
[2]   Are some comparative nutrition claims misleading? The role of nutrition knowledge, ad claim type and disclosure conditions [J].
Andrews, JC ;
Burton, S ;
Netemeyer, RG .
JOURNAL OF ADVERTISING, 2000, 29 (03) :29-42
[3]   Meta-analyses of the effectiveness of warning labels [J].
Argo, JJ ;
Main, KJ .
JOURNAL OF PUBLIC POLICY & MARKETING, 2004, 23 (02) :193-208
[4]  
Brewer W., 1984, Handbook of social cognition, V1, P119
[5]   National surveillance of emergency department visits for outpatient adverse drug events [J].
Budnitz, Daniel S. ;
Pollock, Daniel A. ;
Weidenbach, Kelly N. ;
Mendelsohn, Aaron B. ;
Schroeder, Thomas J. ;
Annest, Joseph L. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (15) :1858-1866
[6]  
Consumer Healthcare Products Association, 2011, INGR DOS TRANSF RX T
[7]  
Consumer Healthcare Products Association, 2011, OTC RET SAL 19642010
[8]  
Consumer Healthcare Products Association, 2011, OTC FACTS FIG
[9]   How well do young people follow the label? An investigation of four classes of over-the-counter drugs [J].
Ellen, PS ;
Bone, PF ;
Stuart, EW .
JOURNAL OF PUBLIC POLICY & MARKETING, 1998, 17 (01) :70-85
[10]  
Ferguson J M, 1987, J Health Care Mark, V7, P37